Envista Holdings Corporation
Healthcare sector | Medical Instruments & Supplies industry
Metrics for NVST
| Price | $25.81 |
|---|---|
| Shares Outstanding | 162.98M |
| All-Time Low | $10.08 |
| 52-Week Low | $14.22 |
Balance Statement Metrics
| Net Cash / Share | $0 |
|---|---|
| Net Current Assets / Share | $-3.35 |
| Net Tangible Assets / Share | $0.74 |
| Shares Outstanding Ave Change (Annual) | 0.12% |
| Shares Δ YoY | -4.88% |
| Avg CA Burn (Annual %) | 12.76% (as of 2-20-2026) |
| Avg CA Burn (Quarterly %) | 3.19% (as of 2-20-2026) |
Earning Metrics
| Max Earning Power / Share | $6.19 |
|---|---|
| Adjusted Earning Power |
$1.92
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
|
| Non-Cash Charges to Market Cap |
0.89%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
|
| Avg EBITDA (5Y) | 255M (as of 2-20-2026) |
| Avg EBITDA (5Q) | 89.4M (as of 2-20-2026) |
| Avg Net Income (5Y) | -232.2M (as of 2-20-2026) |
| Avg Net Income (5Q) | 9.6M (as of 2-20-2026) |
Indicators
| Dividend indicators | Value | Date |
|---|---|---|
| Current Dividend Streak | No | 2-20-2026 |
| Consecutive Years Paid | No | 2-20-2026 |
| Pays Dividend | No | 2-20-2026 |
| Income indicators | Value | Date |
|---|---|---|
| EBITDA Positive | Yes | 2-20-2026 |
| Net Income Positive | Yes | 2-20-2026 |
| Current Dividend Streak | No | 2-20-2026 |
Metric History Explorer
Pick a metric to view its history table and chart.
Tangible Book Value Per Share History
Formula: Tangible Book Value / shares from balance statements. Includes 5 quarterly + 4 annual.
Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).
| Report Date | Period | TBV / Share | Tangible Book Value | Shares Used |
|---|---|---|---|---|
| 2025-12-31 | Quarterly | $0.74 | 120.9M ($120,900,000) | 163.8M (163,800,000) |
| 2025-12-31 | Annual | $0.74 | 120.9M ($120,900,000) | 163.8M (163,800,000) |
| 2025-09-30 | Quarterly | $0.48 | 79.7M ($79,700,000) | 165M (165,000,000) |
| 2025-06-30 | Quarterly | $0.62 | 103.3M ($103,300,000) | 166.8M (166,800,000) |
| 2025-03-31 | Quarterly | $0.48 | 82.5M ($82,500,000) | 171.5M (171,500,000) |
| 2024-12-31 | Quarterly | $0.13 | 23M ($23,000,000) | 172.2M (172,200,000) |
| 2024-12-31 | Annual | $0.13 | 23M ($23,000,000) | 172.2M (172,200,000) |
| 2023-12-31 | Annual | $-0.42 | -72.3M ($-72,300,000) | 171.5M (171,500,000) |
| 2022-12-31 | Annual | $-2.31 | -376.4M ($-376,400,000) | 163.2M (163,200,000) |
Revenue History (Annual)
Revenue from income statements. Includes 4 annual.
Chart plots one annual Revenue point per report date.
| Report Date | Revenue |
|---|---|
| 2025-12-31 | 2.7B ($2,719,500,000) |
| 2024-12-31 | 2.5B ($2,510,600,000) |
| 2023-12-31 | 2.6B ($2,566,500,000) |
| 2022-12-31 | 2.6B ($2,569,100,000) |
Dividend Payments
Historical cash dividends per share from Yahoo ex-dividend dates.
| Date | Dividend / Share |
|---|---|
| No dividend payment history available yet | |
Shares Outstanding Changes
| Date | Shares Outstanding | Delta |
|---|---|---|
| 2026-04-10 | 162,980,850 | -894,547 |
| 2026-02-17 | 163,875,397 | -550,836 |
Short Interest Changes
Latest short-interest change: 11,022,995 shares (7.58% of float) | Days to cover: 4.98
| Date | Short Interest | Delta | Δ % |
|---|---|---|---|
| 2026-04-27 | 11,022,995 shares | +1,331,263 | +13.74% |
| 2026-04-13 | 9,691,732 shares | +2,395,003 | +32.82% |
| 2026-03-24 | 7,296,729 shares | -219,165 | -2.92% |
| 2026-03-11 | 7,515,894 shares | -450,363 | -5.65% |
| 2026-02-26 | 7,966,257 shares | -120,906 | -1.50% |
| 2026-02-11 | 8,087,163 shares | -2,457,649 | -23.31% |
Interesting Volume Days
Volume/ratio use shares outstanding as of the event date (frozen).
| Date | Volume | Shares Outstanding | Volume / Shares | Price |
|---|---|---|---|---|
| No interesting volume events | ||||
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.